HTD1801 as a multisystem cardio‑kidney‑metabolic therapy in type 2 diabetes: phase 3 SYMPHONY Trials demonstrate early CKM risk modification
28 August 2026 (08:57 - 09:21)
Organised by: 
About the speaker
Brugge (Belgium)
3 More presentations in this session
Associate Professor A. Navar (Dallas, US)
Doctor R. Giugliano (Boston, US)
Doctor C. Xu (CN)
Doctor T. Li (Xi'an, CN)
Access the full session
The Event
ESC Congress 2026
28 August 2026
08:57 CET
You may be interested in
Congress Presentation
Congress Session
1 September 2024
Congress Session
Congress Session
